Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1

NCT: NCT06601686 · RECRUITING

NCT IDNCT06601686
StatusRECRUITING
Start Date2025-01-08
Completion2028-01

Brief Summary

The goal of this clinical trial is to learn whether brain stimulation technology can help people reach a meditative state quickly and easily without years of meditation training. The researchers want to see if this will help people distance themselves from their thoughts and feeling, and if this will lead to improvements in openness and wellbeing the same way meditation can. Participants will: * Complete questionnaires * Perform a guided meditation task (The Bell Task) * Wear a high density electrocochleography (hdEEG) cap * Undergo brain stimulation * Perform cognitive tasks

Frequently Asked Questions

What is Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1?

Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1 is a clinical trial registered under NCT06601686. Current status: RECRUITING.

What is the status of NCT06601686?

The current status of NCT06601686 (Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1) is: RECRUITING.

When did Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1 start?

Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1 started on 2025-01-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.